OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 68 filers reported holding OCULAR THERAPEUTIX INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $6,000 | +100.0% | 700 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | +50.0% | 700 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 700 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -40.0% | 700 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | -16.7% | 700 | -50.0% | 0.00% | – |
Q4 2017 | $6,000 | +50.0% | 1,400 | +100.0% | 0.00% | – |
Q3 2017 | $4,000 | -33.3% | 700 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q1 2017 | $6,000 | -68.4% | 700 | -68.2% | 0.00% | -100.0% |
Q4 2016 | $19,000 | 0.0% | 2,200 | -18.5% | 0.00% | 0.0% |
Q3 2016 | $19,000 | +533.3% | 2,700 | +285.7% | 0.00% | – |
Q2 2016 | $3,000 | -57.1% | 700 | 0.0% | 0.00% | – |
Q1 2016 | $7,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q4 2015 | $7,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |